Family Medicine
IVF add-ons: why you should be cautious of these expensive procedures if you’re trying to conceive.
1 Apr, 2022 | 08:44h | UTCRelated:
Randomized Trial: Acupuncture Not Effective for Improving the Likelihood of In Vitro Fertilization
Research: Transfer of Fresh versus Frozen Embryos in Ovulatory Women
Practice review: Evidence-based and effective management of anemia in palliative care patients.
1 Apr, 2022 | 08:21h | UTC
Practice review: Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD).
1 Apr, 2022 | 08:29h | UTC
Practice review: Evidence-based and effective management of fatigue in patients with advanced cancer.
1 Apr, 2022 | 08:26h | UTC
WHO recommendations on maternal and newborn care for a positive postnatal experience.
31 Mar, 2022 | 08:47h | UTCNews Release: WHO urges quality care for women and newborns in critical first weeks after childbirth – World Health Organization
Commentary: Postnatal care: WHO highlights urgency of physical and mental support – The BMJ
RCT: Early treatment with ivermectin does not improve outcomes in patients with Covid-19.
31 Mar, 2022 | 08:41h | UTCCommentary: Ivermectin does not prevent COVID-19 hospitalization, a new study says – NPR
Commentary on Twitter
Ivermectin: the largest randomized, double-blind trial yet conducted, with early treatment, indicates there is no difference compared with placebo. It doesn't work. Period. https://t.co/wiFygjRgkk
just published @NEJM pic.twitter.com/uZ0mMZnO0E— Eric Topol (@EricTopol) March 30, 2022
USPSTF Draft Recommendation Statement: the current evidence is insufficient to recommend screening for obstructive sleep apnea in asymptomatic individuals.
31 Mar, 2022 | 08:42h | UTCCommentary: USPSTF: Evidence Lacking for OSA Screening in Asymptomatic Adults – HealthDay
Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study in England.
31 Mar, 2022 | 08:29h | UTCInvited Commentary: Importance of understanding the reinfection risk of COVID-19 in children – The Lancet Child & Adolescent Health
Commentary on Twitter
Everything we know about #SARSCoV2 tells us that first infection reduces (but doesn’t eliminate) the risk & SEVERITY of further infections, even with new variants. Here is our paper showing this with delta reinfections in kids (work on omicron reinfections in progress)👇 https://t.co/3gDPBHRu18
— Shamez Ladhani (@ShamezLadhani) March 30, 2022
Meta-analysis of randomized trials: Clopidogrel is better than aspirin for the secondary prevention of cardiovascular events.
31 Mar, 2022 | 08:31h | UTCCommentary: Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention – TCTMD
Commentary on Twitter
Happy to share our paper in @ESC_Journals. In this meta-analysis of randomized trials, we found that as compared with aspirin, P2Y12i was associated with 11% and 19% reduction in MACE and MI respectively. https://t.co/Y3Gstzgfu6
— Devika Aggarwal (@devikagg) March 30, 2022
Case-control study: In children 5 to 11 years of age, the Pfizer vaccine showed an effectiveness of 68% against hospitalization caused by the Omicron variant.
31 Mar, 2022 | 08:37h | UTCCommentary: COVID vaccination of children age 5-11 cut omicron hospitalizations by 68% – Children’s Hospital Boston
Commentary on Twitter
BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age. https://t.co/mQcchQqbtH pic.twitter.com/Qzy8qKg1wC
— NEJM (@NEJM) March 30, 2022
M-A: Psychological interventions for chronic, non-specific low back pain.
31 Mar, 2022 | 08:20h | UTCNews Release: Study sheds light on psychological therapies for chronic low back pain – British Medical Journal
Cohort Study: Mortality associated with mental disorders and comorbid general medical conditions.
31 Mar, 2022 | 08:15h | UTCMortality Associated With Mental Disorders and Comorbid General Medical Conditions – JAMA Psychiatry
Commentary: People with Mental Disorders, General Comorbid Conditions Have 11-Year Reduced Life Expectancy – HCP Live
Rickets guidance: part II—management.
31 Mar, 2022 | 08:08h | UTCRickets guidance: part II—management – Pediatric Nephrology
Related: Rickets guidance: part I—diagnostic workup.
The incidence of adult-onset Type 1 Diabetes: a systematic review from 32 countries and regions.
31 Mar, 2022 | 07:52h | UTC
[Preprint] Retrospective cohort study: second booster vaccine and Covid-19 mortality in adults 60 to 100 years old.
30 Mar, 2022 | 10:44h | UTCSecond Booster Vaccine and Covid-19 Mortality in Adults 60 to 100 Years Old – Research Square
Commentaries:
Huge Study Finds Second COVID-19 Booster is ‘Life-saving’ for Over 60s – Health Policy Watch
Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly – News Medical
U.S. approves second Covid-19 booster for people 50 and older and immunocompromised individuals.
30 Mar, 2022 | 10:42h | UTCU.S. approves second Covid-19 booster for people 50 and older – STAT
FDA OKs second COVID booster shot for older Americans – CIDRAP
Study shows overtreatment of diabetes common in nursing home residents with type 2 diabetes.
30 Mar, 2022 | 10:27h | UTCCommentaries:
Overtreatment of T2DM Common Among VA Nursing Home Residents – HealthDay
Diabetes treatment deintensification uncommon in nursing home residents – medwire News
Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study.
30 Mar, 2022 | 10:24h | UTC
Commentary on Twitter
See our new paper prepared within @IHME_UW! #BMJ
Life expectancy ≥70 has continued to rise globally. #Disability burden remained constant, suggesting the need to enhance public health and intervention programmes to improve wellbeing among older adults.https://t.co/TegmWQ3048
— Maciej Banach (@maciejbanach) March 14, 2022
Retrospective Cohort Study: Risks for anaphylaxis with intravenous iron formulations.
30 Mar, 2022 | 10:16h | UTCRisks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University
Commentary: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay
Systematic Review: Probiotics for treatment of chronic constipation in children.
30 Mar, 2022 | 10:12h | UTCProbiotics for treatment of chronic constipation in children – Cochrane Library
Summary: Probiotics for treatment of chronic constipation in children – Cochrane Library
Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019.
30 Mar, 2022 | 09:55h | UTCInvited Commentary: 30-year NCD burden data for EU adolescents merit close attention – The Lancet Child & Adolescent Health (free registration required)
Commentary on Twitter (thread – click for more)
New #GBD study: #NCD mortality substantially declined among #adolescents (10-24 years) in the #EU between 1990 and 2019. But disability has remained mostly unchanged, with a concerning rise in disability burden attributed to mental disorders https://t.co/V94kubDqOR #IAHW2022
— The Lancet Child & Adolescent Health (@LancetChildAdol) March 25, 2022
Cohort Study: Prenatal occupational disinfectant exposure linked to increased risk of childhood allergies.
30 Mar, 2022 | 08:48h | UTCCommentary: Disinfectant use by pregnant women may increase risk for asthma and eczema in children – BMJ/News Medical
Commentary on Twitter
Disinfectant use during pregnancy linked to childhood asthma and eczema, suggests @OEM_BMJ research https://t.co/90JYoTFHpo pic.twitter.com/zlqouZWQSM
— BMJ Group (@bmj_company) March 29, 2022
Cluster RCT: A household salt substitution intervention is a cost-effective intervention for preventing stroke and improving quality of life.
29 Mar, 2022 | 10:16h | UTCCommentary: ACC: Use of Salt Substitute to Prevent Stroke Is Cost-Saving – HealthDay
Related:
Former CDC director: Low sodium salt could save millions of lives – CNN
Is salt good for you after all? The evidence says no.
Systematic Review: Altered dietary salt intake for people with chronic kidney disease.
New WHO benchmarks help countries reduce salt intake and save lives.
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Meta-Analysis: Effect of Reduction in Dietary Sodium on Blood Pressure Levels
Meta-analysis of randomized trials: GLP1 receptor agonists increase the risk of gallbladder and biliary diseases (RR, 1.37; 95% CI, 1.23-1.52).
29 Mar, 2022 | 10:02h | UTCAssociation of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials – JAMA Internal Medicine (free for a limited period)
Commentary: GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder?— Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug – MedPage Today (free registration required)
Cohort Study: Preconception paternal use of metformin linked to increased risk of congenital problems in offspring.
29 Mar, 2022 | 10:04h | UTCPreconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: